Title:
DGAT1阻害剤の使用
Document Type and Number:
Japanese Patent JP2013523746
Kind Code:
A
Abstract:
The present invention relates to the use of a DGAT1 inhibitor, or a pharmaceutically acceptable salt or ester thereof, for the prevention, delay of progression or treatment of a disease or condition which is selected from chylomicronemia syndrome, familial chylomicronemia syndrome and Type V hyperlipoproteinemia. The present invention further relates to the use of a pharmaceutical composition comprising a DGAT1 inhibitor, or a pharmaceutically acceptable salt or ester thereof, for the prevention, delay of progression or treatment of a disease or condition which is selected from chylomicronemia syndrome, familial chylomicronemia syndrome and Type V hyperlipoproteinemia.
Inventors:
Charles Myers
Serrano-Wu, Mitchell, H.
Thulen, Tom
Serrano-Wu, Mitchell, H.
Thulen, Tom
Application Number:
JP2013502706A
Publication Date:
June 17, 2013
Filing Date:
March 29, 2011
Export Citation:
Assignee:
Novartis Age
International Classes:
A61K45/00; A61K31/444; A61P1/16; A61P1/18; A61P3/06; A61P17/00; A61P25/28; A61P27/02; A61P43/00
Domestic Patent References:
| JP2006166742A | 2006-06-29 | |||
| JP2009514780A | 2009-04-09 | |||
| JP2009532355A | 2009-09-10 |
Foreign References:
| WO2009119534A1 | 2009-10-01 | |||
| WO2009040410A1 | 2009-04-02 |
Other References:
JPN5013006252; ＺＨＡＯ: 'ＶＡＬＩＤＡＴＩＯＮ ＯＦ ＤＩＡＣＹＬ ＧＬＹＣＥＲＯＬＡＣＹＬＴＲＡＮＳＦＥＲＡＳＥ Ｉ ＡＳ Ａ ＮＯＶＥＬ ＴＡＲＧＥＴ ＦＯＲ ＴＨＥ ＴＲＥＡＴＭＥＮＴ 以下備考' ＪＯＵＲＮＡＬ ＭＥＤＩＣＡＬ ＣＨＥＭＩＳＴＲＹ Ｖ５１, 20080110, Ｐ３８０-３８３
Attorney, Agent or Firm:
Hiroshi Kobayashi
Norio Omori
Yasuhito Suzuki
Norio Omori
Yasuhito Suzuki